Citations

Showing 10 of 108104 citations.

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
Heiblig, Maël , Ferrada, Marcela A. , Koster, Matthew T., Barba, Thomas , Gerfaud‐Valentin, Mathieu , Mékinian, A. , Coelho, Henrique , Fossard, Gaëlle , Barraco, Fiorenza , Galicier, Lionel , Bienvenu, Boris , Hirsch, Pierre , Vial, Guillaume , Boutin, Anne Blandine, Guenno, G. Le , Bigot, Adrien , Kermani, Tanaz A. , Grayson, Peter C. , Beck, David B. , Fenaux, Pierre , Sujobert, Pierre , Mékinian, Arsène , Galland, Joris , Le Guenno, Guillaume , Bigot, Adrien , Jamilloux, Yvan , Heiblig, Mael , Ferrada, Marcela A , Koster, Matthew, Warrington, Kenneth J. , Patel, Bhavisha A.

Mayo Clinic

Blood | May 24, 2022 | Volume: 140 | Issue: 8 | Pages: 927-931

10.1182/blood.2022016642 | PMID 35609174 Get It

VEXAS syndrome (vacuoles in myeloid progenitors, E1 ubiquitin activating enzyme, X-linked, autoinflammatory manifestations and somatic) is an autoinflammatory condition caused by somatically acquired UBA1 mutations. Heiblig et al report on an international retrospective analysis of 30 patients with VEXAS syndrome treated with different Janus kinase (JAK) inhibitors, finding encouraging evidence supporting the use of the JAK1/2 inhibitor ruxolitinib with clinical remissions and reductions in steroid use seen in the majority of patients.
Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease
Vöglein, Jonathan , Morris, John C. , Dieterich, Marianne , Preische, Oliver, Hofmann, Anna, Hassenstab, Jason , Fagan, Anne M. , Noble, James M. , Berman, Sarah , Graff‐Radford, Neill R. , Farlow, Martin R. , Chhatwal, Jasmeer P. , Salloway, Stephen , Xiong, Chengjie , Cairns, Nigel J., Perrin, Richard J. , Day, Gregory S. , Mori, Hiroshi , Suzuki, Kazushi , Masters, Colin L. , Goate, Alison , Buckles, Virginia, Fox, Nick C. , Chrem, Patricio, Ringman, John M. , Yakushev, Igor , Laske, Christoph , Bateman, Randall J. , Network, for the Dominantly Inherited Alzheimer, Day, Gregory S , Bateman, Randall J , Masters, Colin L , Vöglein, Jonathan , Xiong, Chengjie , Fox, Nick C , Hassenstab, Jason , Morris, John C , Goate, Alison M , Berman, Sarah , Noble, James M , Franzmeier, Nicolai , McDade, Eric , Simons, Mikael , Benzinger, Tammie L.S. , Ghetti, Bernardino , Xiong, Chengjie , Karch, Celeste M. , Martins, Ralph N. , Sánchez‐Valle, Raquel , Shimada, Hiroyuki , Ikeuchi, Takeshi , Schofield, Peter R. , Allegri, Ricardo , Jucker, Mathias , Höglinger, Günter U. , Danek, Adrian , Network, for the Dominantly Inherited Alzheimer

Mayo Clinic

Alzheimer's & Dementia | May 24, 2022 | Volume: 19 | Issue: 2 | Pages: 632-645

10.1002/alz.12684 | PMID 35609137 Get It

AbstractIntroductionAs knowledge about neurological examination findings in autosomal dominant Alzheimer disease (ADAD) is incomplete, we aimed to determine the frequency and significance of neurological examination findings in ADAD.MethodsFrequencies of neurological examination findings were compared between symptomatic mutation carriers and non mutation carriers from the Dominantly Inherited Alzheimer Network (DIAN) to define AD neurological examination findings. AD neurological examination findings were analyzed regarding frequency, association with and predictive value regarding cognitive decline, and association with brain atrophy in symptomatic mutation carriers.ResultsAD neurological examination findings included abnormal deep tendon reflexes, gait disturbance, pathological cranial nerve examination findings, tremor, abnormal finger to nose and heel to shin testing, and compromised motor strength. The frequency of AD neurological examination findings was 65.1%. Cross‐sectionally, mutation carriers with AD neurological examination findings showed a more than two‐fold faster cognitive decline and had greater parieto‐temporal atrophy, including hippocampal atrophy. Longitudinally, AD neurological examination findings predicted a significantly greater decline over time.DiscussionADAD features a distinct pattern of neurological examination findings that is useful to estimate prognosis and may inform clinical care and therapeutic trial designs.
Use of a Viral Filter to Reduce Exposure to Exhaled Aerosol Does Not Affect Methacholine Dose Delivery During Bronchoprovocation Testing
Subat, Yosuf W., Meyer, Todd J., Torgerud, Keith D, Scanlon, Paul D., Lim, Kaiser G. , Niven, Alexander S.

Mayo Clinic

Respiratory Care | May 24, 2022 | Volume: 67 | Issue: 8 | Pages: 899-905

10.4187/respcare.09703 | PMID 35610032 Get It

BACKGROUND: Methacholine challenge testing (MCT) is a common bronchoprovocation technique used to assess airway hyper-responsiveness. We previously demonstrated that the addition of a viral filter to the nebulizer exhalation limb substantially reduced expelled particles during MCT. Our aim was to evaluate whether this modification affects the delivered dose of methacholine. METHODS: A mechanical ventilator was connected to a lung simulator with breathing frequency 15 breaths/min, tidal volume 500 mL, inspiratory-expiratory ratio 1:1, with a sinusoidal waveform. We compared methacholine dose delivery using the Hudson Micro Mist or AeroEclipse II BAN nebulizers powered by either a dry gas source or a compressor system. A filter placed in line between the nebulizer and test lung was weighed before and after 1 min of nebulized methacholine delivery. Mean inhaled mass was measured with and without a viral filter on the exhalation limb. Dose delivery was calculated by multiplying the mean inhaled mass by the respirable fraction (particles < 5 μm) and inhalation time. Unpaired t test was used to compare methacholine dose delivery with and without viral filter placement. RESULTS: The addition of a viral filter did not significantly affect methacholine dose delivery across all devices tested. Using a 50-psi dry gas source, dose delivered with or without a viral filter did not differ with the Hudson (422.3 μg vs 282.0 μg, P = .11) or the AeroEclipse nebulizer (563.0 μg vs 657.6 μg, P = .59). Using the compressor, dose delivered with and without a viral filter did not differ with the Hudson (974.0 μg vs 868.0 μg, P = .03) or the AeroEclipse nebulizer (818.0 μg vs 628.5 μg, P = .42). CONCLUSIONS: The addition of a viral filter to the nebulizer exhalation limb did not affect methacholine dose during bronchoprovocation testing. Routine use of a viral filter should be considered to improve pulmonary function technician safety and infection control measures during the ongoing COVID-19 pandemic.
Isolated Elevation in Lung Residual Volume Is Associated With Airway Diseases
Samhouri, Bilal F. , Poliszuk, Daniel, Hoskote, Sumedh S. , Kanj, Amjad N, Kanj, Amjad , Lim, Kaiser G.

Mayo Clinic

Respiratory Care | May 24, 2022 | Volume: 67 | Issue: 7 | Pages: 842-849

10.4187/respcare.09687 | PMID 35610031 Get It

BACKGROUND: Residual volume (RV) is a derived lung compartment that correlates with air trapping in the context of air flow obstruction on spirometry. The significance of an isolated elevation in RV in the absence of other pulmonary function test (PFT) abnormalities is not well defined. We sought to assess the clinical and radiologic findings associated with isolated elevation in RV. METHODS: We searched our out-patient PFT database at Mayo Clinic (Rochester, Minnesota) from 2016–2018 for adult patients with isolated elevation in RV. We defined isolated elevation in RV as RV ≥ upper limit of normal or ≥ 130% predicted with normal total lung capacity (TLC), spirometry, and diffusion capacity of the lung for carbon monoxide (D LCO ). We then matched this high-RV group by age and sex to an equal number of individuals with normal RV, TLC, spirometry, and D LCO (normal-RV group). RESULTS: We identified 169 subjects with isolated elevation in RV on PFTs, with a median age of 73 y; 55.6% were female, and median body mass index was 26.8 (vs 29.8 in the normal-RV group). The median RV was 3.08 L (134% predicted, interquartile range [IQR] 130–141) in the high-RV group and 2.26 L (99% predicted, IQR 90–109) in the normal-RV group (P < .001). Subjects with high RV were more likely to have smoked (54% vs 40%, P = .01) and almost twice as likely to have a maximum voluntary ventilation < 30 times the FEV 1 (21% vs 12%, P = .02). Clinically, asthma (21% vs 11%, P = .01) and non–tuberculous mycobacterial lung infections (12% vs 2%, P = .001) were more prevalent in the high-RV group. On chest computed tomography, bronchiectasis (31% vs 15%, P = .008), bronchial thickening or mucus plugging (46% vs 22%, P < .001), and emphysema (13% vs 5%, P = .046) were more common in the high-RV group. CONCLUSIONS: Isolated elevation in RV on PFTs is a clinically relevant abnormality associated with airway-centered diseases.
Paroxysmal supine hypoxaemia with hyperthyroidism and atrial fibrillation: a case report of a diagnostic challenge
Liu, Liang Yen , Reddy, Yogesh N.V. , Niven, Alexander S. , Hu, Tiffany , Mulpuru, Siva K. , Cullen, Michael W. , Hu, Tiffany Y, Larson, Kathryn F. , Nishimura, Rick , Niven, Alexander S

Mayo Clinic

European Heart Journal - Case Reports | May 24, 2022 | Volume: 6 | Issue: 6 | Pages: No page available

10.1093/ehjcr/ytac214 | PMID 35734629 Get It

Abstract Background A patent foramen ovale (PFO) is a persistent embryonic defect in the interatrial septum. Platypnoea-orthodeoxia syndrome is characterized by positional hypoxaemia that is most commonly due to right-to-left shunting through a PFO. Dynamic right-to-left shunting through a PFO can also exacerbate positional hypoxaemia without platypnea-orthodeoxia syndrome. Case summary A 78-year-old woman with hyperthyroidism and paroxysmal atrial fibrillation (AF) presented with positional hypoxaemia exacerbated by supine positioning. Diagnostic testing revealed intermittent right-to-left shunting through a PFO triggered by worsening atrial functional tricuspid regurgitation and elevated right atrial pressures. Diuresis, rate control, and thyroidectomy initially led to resolution of positional hypoxaemia, but recurrent AF episodes triggered right-to-left shunting with recurrent desaturation. Left atrial and cavo-tricuspid isthmus ablation led to restoration of normal sinus rhythm and resolution of positional hypoxaemia without PFO closure. Discussion The clinical presentation of intermittent intracardiac right-to-left shunting can mimic decompensated heart failure with pulmonary oedema. Persistent hypoxaemia out of proportion to the degree of pulmonary oedema and minimally responsive to supplemental O2 should raise suspicion for right-to-left shunt aetiology. Positional arterial blood gases can facilitate the diagnostic evaluation of refractory hypoxaemia in cases of suspected shunting. Diagnostic imaging for PFO detection includes both transthoracic and transesophageal echocardiography with Valsalva manoeuver and agitated saline injection. Closure of a PFO for management of arterial deoxygenation syndromes should not be performed before treating other causes of arterial deoxygenation and optimizing factors that may exacerbate shunting across the PFO.
Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
Helgeson, Scott A. , Moss, John E. , Zeiger, Tonya K., Taylor, Bryan J , Helgeson, Scott A , Burger, Charles D. , Taylor, Bryan J.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 24, 2022 | Volume: 206 | Issue: 5 | Pages: 650-651

10.1164/rccm.202204-0762le | PMID 35608525 Get It

Impact of β-blockers on Survival Outcomes in Patients with Unresectable Hepatocellular Carcinoma
Altshuler, Ellery , Kallumkal, Govind, Gao, Hanzhi, Wilson, Jake, Ouni, A. El , Leo, Edward De , Hanayneh, Wissam , Pan, Kelsey , Ouni, Ahmed, Aryan, Mahmoud , Ouni, Ahmed

Mayo Clinic

Hepatic Oncology | May 24, 2022 | Volume: 9 | Issue: 2 | Pages: No page available

10.2217/hep-2021-0010 | PMID 35665305 Get It

Celiac Disease and Thrombotic Events: Systematic Review of Published Cases
Pantić, Nikola , Pantić, Ivana , Jevtic, Dorde , Mogulla, Vanajakshi , Oluic, Stevan , Durdevic, Momcilo , Nordin, Terri , Jecmenica, Mladen , Milovanovic, Tamara, Gavrancic, Tatjana , Dumic, Igor , Alempijević, Tamara , Alempijevic, Tamara , Dumic, Igor , Jevtic, Djordje

Mayo Clinic

Nutrients | May 24, 2022 | Volume: 14 | Issue: 10 | Pages: 2162

10.3390/nu14102162 | PMID 35631302 Get It

Extraintestinal manifestations of celiac disease (CD) should be considered, even in patients without typical intestinal symptoms. The aim of our study is to examine the literature regarding the occurrence of thrombotic events in CD, and to synthesize the data from case reports and case series. A systematic review of the literature was conducted by searching the Pub-Med/MEDLINE database, from the date of database inception to January 2022, to identify published cases and case series on this topic, in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. A total of 55 cases were included in the study. The majority of patients were previously healthy individuals, with no comorbidities. In less than one-third of the cases (30.91%), the diagnosis of CD was established before the onset of thrombosis, while in the remaining cases (34.54%), thrombosis preceded the diagnosis or was diagnosed concomitantly with CD. The most common sites for thrombosis occurrence were hepatic veins (30.91%), while thrombosis of cerebral blood vessels, deep venous thrombosis of lower extremities, and pulmonary thromboembolism were less frequent. Thrombosis was most commonly isolated to one site only (78.18%). In 69.09% of cases (n = 38), some form of anticoagulation, along with a gluten-free diet, was initiated.
Deep Neural Network for Cardiac Magnetic Resonance Image Segmentation
Chen, David , Bhopalwala, Huzefa , Dewaswala, Nakeya , Arunachalam, Shivaram P. , Enayati, Moein , Farahani, Nasibeh Zanjirani , Lokineni, Sravani, Bos, J. Martijn , Geske, Jeffrey B. , Ackerman, Michael J. , Araoz, Philip A. , Arruda‐Olson, Adelaide M. , Arunachalam, S P , Bos, Johan M , Geske, Jeffrey B , Pasupathy, Kalyan S. , Noseworthy, Peter A. , Arsanjani, Reza , Erickson, Bradley J.

Mayo Clinic

Journal of Imaging | May 23, 2022 | Volume: 8 | Issue: 5 | Pages: 149

10.3390/jimaging8050149 | PMID 35621913 Get It

The analysis and interpretation of cardiac magnetic resonance (CMR) images are often time-consuming. The automated segmentation of cardiac structures can reduce the time required for image analysis. Spatial similarities between different CMR image types were leveraged to jointly segment multiple sequences using a segmentation model termed a multi-image type UNet (MI-UNet). This model was developed from 72 exams (46% female, mean age 63 ± 11 years) performed on patients with hypertrophic cardiomyopathy. The MI-UNet for steady-state free precession (SSFP) images achieved a superior Dice similarity coefficient (DSC) of 0.92 ± 0.06 compared to 0.87 ± 0.08 for a single-image type UNet (p < 0.001). The MI-UNet for late gadolinium enhancement (LGE) images also had a superior DSC of 0.86 ± 0.11 compared to 0.78 ± 0.11 for a single-image type UNet (p = 0.001). The difference across image types was most evident for the left ventricular myocardium in SSFP images and for both the left ventricular cavity and the left ventricular myocardium in LGE images. For the right ventricle, there were no differences in DCS when comparing the MI-UNet with single-image type UNets. The joint segmentation of multiple image types increases segmentation accuracy for CMR images of the left ventricle compared to single-image models. In clinical practice, the MI-UNet model may expedite the analysis and interpretation of CMR images of multiple types.